Avalere Health has appointed Wendy Jory as Senior Vice President, Market Access. In this pivotal role, Jory will lead the market access team, a core part of the company’s Advisory capability that helps US and global biopharmaceutical and life sciences clients navigate pricing, contracting and reimbursement at a time when the path from approval to patient has never been more complex.
Amar Urhekar, CEO, said: “As a cross-functional leader with experience managing pricing and access strategy across more than 60 markets, she is the ideal person to lead Avalere Health’s expanding global market access footprint. Her scientific background, commercial rigor, and global perspective will enable our clients to turn access challenges into opportunities.”
Jory was most recently Medicine Commercialization Lead, Product and Portfolio Strategy at GSK, leading global cross-functional teams to shape commercialisation, life cycle and business development strategy for immunology, respiratory, oncology and rare disease assets. Before that, she spent five years as GSK’s Head of Pricing and Contracting Strategies for Global Market Access, where she built the company’s global pricing and contracting capabilities and developed innovative models to improve access to specialty and rare disease therapies. Earlier in her career, she spent more than a decade in strategic leadership positions at Life Technologies, now part of Thermo Fisher Scientific.
Jory commented: “What drew me to Avalere Health is the strength of its integrated model. Access decisions no longer sit in a silo – they depend on policy, evidence, medical insight and how a product’s value is communicated. Few organisations bring all of that together under one roof.”
At Avalere Health, Wendy will deepen collaboration between the Advisory capability’s market access team and its policy and evidence and strategy teams, ensuring that clients’ access strategies anticipate the pricing and reimbursement implications of a fast-changing policy and market environment. Beyond this, Wendy will partner closely with Avalere Health’s Medical and Marketing leaders to build connected strategies that carry the value story from evidence generation through to payer and patient, both in the US and globally.